Article
[Genetic and immunologic risks for development of type 1 diabetes--experiences from an intervention trial].
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke - 30 Sept 2000
Undlien D E, Joner G, Dahl-Jørgensen K, Rønningen K S, Nicol-Smith L, Torjesen P A, Søvik O
Abstract excerpt
BACKGROUND: Type 1 diabetes is a common multi-factorial disease. Recently, promising attempts have been made at preventing the disease in individuals at risk. We present our experiences as participants in an international multicentre intervention trial, the European Nicotinamide Diabetes Intervention Trial (ENDIT). The aim is to prevent prediabetic individuals from becoming overtly diabetic by the use of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
